AMGEN INC.
Federal contract awards won by AMGEN INC. (UEI D92HARF1LKA9), 2019–2023 — public record from USAspending.
Showing awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
2
awards
$31,423,307
total value
1
agency
Agencies buying from AMGEN INC.
What AMGEN INC. sells
Awards
NPLATE ADMINISTRATION KIT DEVELOPMENT FOR THE TREATMENT OF APPROVED INDICATIONS, INCLUDING ACUTE RADIATION SYNDROME (ARS)
Department of Health and Human Services · $7,290,924 · Aug 28, 2023
THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO
Department of Health and Human Services · $24,132,383 · Sep 26, 2019
Researching this competitor? BidCatch doesn't just show you what they won — it sends you the open bids in your trade every morning, before they're awarded. Free for 14 days, then $49.99/month.
Search open bids